222 related articles for article (PubMed ID: 22056566)
1. Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap?
Rizvi S; Schoen RE
Am J Gastroenterol; 2011 Nov; 106(11):1872-9. PubMed ID: 22056566
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of intravenous iron dextran and oral iron in inflammatory bowel disease: a case-matched study in clinical practice.
Khalil A; Goodhand JR; Wahed M; Yeung J; Ali FR; Rampton DS
Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1029-35. PubMed ID: 21857526
[TBL] [Abstract][Full Text] [Related]
3. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of iron deficiency anemia in patients with inflammatory bowel disease and gastrointestinal bleeding: iron deficiency anemia working group consensus report.
Akpınar H; Çetiner M; Keshav S; Örmeci N; Törüner M
Turk J Gastroenterol; 2017 Mar; 28(2):81-87. PubMed ID: 28119272
[TBL] [Abstract][Full Text] [Related]
5. Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study.
Lindgren S; Wikman O; Befrits R; Blom H; Eriksson A; Grännö C; Ung KA; Hjortswang H; Lindgren A; Unge P
Scand J Gastroenterol; 2009; 44(7):838-45. PubMed ID: 19330567
[TBL] [Abstract][Full Text] [Related]
6. [Is intravenous iron really useful in inflammatory bowel disease? Would oral iron not be simpler and cheaper?].
Bermejo San José F
Gastroenterol Hepatol; 2009 Jan; 32(1):63-4. PubMed ID: 19174104
[No Abstract] [Full Text] [Related]
7. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
Bailie GR
Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
[TBL] [Abstract][Full Text] [Related]
8. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT
Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342
[TBL] [Abstract][Full Text] [Related]
9. Intravenous iron in inflammatory bowel diseases.
Gomollón F; Gisbert JP
Curr Opin Gastroenterol; 2013 Mar; 29(2):201-7. PubMed ID: 23274316
[TBL] [Abstract][Full Text] [Related]
10. [IV iron or oral iron in anaemic patient with CKD].
Frimat L; Thilly N; Boini S
Nephrol Ther; 2006 Nov; 2 Suppl 5():S347-9. PubMed ID: 17373282
[TBL] [Abstract][Full Text] [Related]
11. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease.
Gisbert JP; Gomollón F
Am J Gastroenterol; 2008 May; 103(5):1299-307. PubMed ID: 18477354
[TBL] [Abstract][Full Text] [Related]
12. Treatment of anaemia in inflammatory bowel disease.
Koutroubakis IE; Karmiris K; Kouroumalis EA
Aliment Pharmacol Ther; 2006 Apr; 23(8):1273-4; author reply 1274-5. PubMed ID: 16611290
[No Abstract] [Full Text] [Related]
13. Fatigue and acute/chronic anaemia.
Bager P
Dan Med J; 2014 Apr; 61(4):B4824. PubMed ID: 24814598
[TBL] [Abstract][Full Text] [Related]
14. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial.
Van Wyck DB; Martens MG; Seid MH; Baker JB; Mangione A
Obstet Gynecol; 2007 Aug; 110(2 Pt 1):267-78. PubMed ID: 17666600
[TBL] [Abstract][Full Text] [Related]
15. Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis.
Lee TW; Kolber MR; Fedorak RN; van Zanten SV
J Crohns Colitis; 2012 Apr; 6(3):267-75. PubMed ID: 22405161
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
Qunibi WY
Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
[TBL] [Abstract][Full Text] [Related]
17. Recombinant erythropoietin for the treatment of anemia in inflammatory bowel disease.
Schreiber S; Howaldt S; Schnoor M; Nikolaus S; Bauditz J; Gasché C; Lochs H; Raedler A
N Engl J Med; 1996 Mar; 334(10):619-23. PubMed ID: 8592524
[TBL] [Abstract][Full Text] [Related]
18. Oral or IV iron in inflammatory bowel disease.
Auerbach M
Am J Gastroenterol; 2012 Jun; 107(6):950; author reply 950-1. PubMed ID: 22664849
[No Abstract] [Full Text] [Related]
19. Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Bonovas S; Fiorino G; Allocca M; Lytras T; Tsantes A; Peyrin-Biroulet L; Danese S
Medicine (Baltimore); 2016 Jan; 95(2):e2308. PubMed ID: 26765407
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of intravenous iron in treating iron deficiency anaemia in patients with inflammatory bowel disease. Are there predictors of response?
Ferreiro-Iglesias R; Barreiro-de-Acosta M; Seijo-Ríos S; Lorenzo A; Domínguez-Muñoz JE
Rev Esp Enferm Dig; 2011 May; 103(5):245-9. PubMed ID: 21619388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
